Randomized Comparison of Piperacillin/Tazobactam Versus Imipenem/Cilastatin in the Treatment of Patients with Intra-abdominal Infection
Treatment of intra-abdominal infections remains a challenge because of their polymicrobial nature and associated mortality risk. Broad-spectrum empiric coverage is usually required. This randomized study compared the efficacy and safety of intravenous piperacillin/tazobactam with those of intravenou...
Main Author: | Alex A. Erasmo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2004-07-01
|
Series: | Asian Journal of Surgery |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1015958409600397 |
Similar Items
-
Retrospective evaluation of piperacillin–tazobactam, imipenem–cilastatin and meropenem used on surgical floors at a tertiary care hospital in Saudi Arabia
by: Eman Youssif, et al.
Published: (2018-07-01) -
A Prospective Randomized Trial of Imipenem-Cilastatin Versus Clindamycin/Tobramycin in the Treatmentof Intra-Abdominal and Pelvic Infections
by: Lionel A Mandell, et al.
Published: (1993-01-01) -
Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial
by: Chen Xiaoping, et al.
Published: (2010-07-01) -
Piperacillin/Tazobactam (ZOSYN)
by: Stephanie M. Culver, et al.
Published: (1996-01-01) -
A multicenter, double-blind, randomized, comparison study of the efficacy and safety of tigecycline to imipenem/cilastatin to treat complicated intra-abdominal infections in hospitalized subjects in China
by: Chen Y, et al.
Published: (2018-11-01)